Quote: -------------------------------------------------------------------------------- Status Update! On Friday, July 19, 2013, status on the HEMAXELLERATE trademark changed to PUBLICATION/ISSUE REVIEW COMPLETE. --------------------------------------------------------------------------------
Quote: -------------------------------------------------------------------------------- The HemXellerate product is an optimized autologous SVF preparation for stimulation of hematopoiesis that is covered by one issued patent and two patent applications. In practice the physician is shipped a kit, which is used to collect adipose tissue, tissue is sent to a central processing facility, and a standardized cellular product is delivered in a ready-to-use manner. Currently the company is developing various uses for the HemXellerate production in conditions involving suppressed hematopoiesis. --------------------------------------------------------------------------------
Quote: -------------------------------------------------------------------------------- Given that the HemXellerate therapy has the potential to treat several if not many diseases in a Trillion Dollar Pharmaceutical Market, the monetary potential for this little company, based on their stem cell therapy alone is huge. --------------------------------------------------------------------------------
BIG $$$-MAKING Things HAPPENING with BMSN to come outta THIS!!!!! ; - )